Skip to main content
SpringerLink
Log in

Molekulare Pathogenese der Malignome des Genitalbereichs

  • Chapter
Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen

Part of the book series: Molekulare Medizin ((MOLMED))

  • 56 Accesses

Zusammenfassung

Tumoren des weiblichen Genitaltrakts weisen besondere epidemiologische Verteilungsmuster auf, die für die onkologische Ursachen- und Grundlagenforschung in den letzten Jahrzehnten richtungsweisende Einsichten und Erkenntnisse ergeben haben. Zum einen finden sich bestimmte erbliche Verteilungs muster insbesondere beim Endometrium- und Ovarialkarzinom, die nahe legten, dass erbliche Prädispositionen in der Pathogenese dieser Tumoren eine wesentliche Rolle spielen. Durch diese Beobachtungen konnten u. a. die zentrale Rolle so wesentlicher Tumorsuppressorgene wie der Brust- und Ovarialkrebsgene BRCA1 und BRCA2, aber auch der DNA-Mismatch-Reparaturgene hMLH1, hMSH2 und hMLH6 beim hereditären Endometriumkarzinom charakterisiert werden. Andererseits fanden sich gerade beim Zervixkarzinom, aber auch dem Vulva- und Vaginalkarzinom epidemiologische Anhaltspunkte für einen sexuell übertragbaren Erreger, die letztendlich zur Entdeckung und Charakterisierung der onkogenen humanen Papillomviren geführt haben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abulafia O, Sherer DM (1999) Automated cervical cytology:meta-analyses of the performance of the AutoPap 300 QC system. Obstet Gynecol Surv 54:469–476

    PubMed  CAS  Google Scholar 

  • Angioli R, Estape R, Mason M, Penalver M (1998) Hereditary and sporadic ovarian cancer: genetic testing and clinical implications. Int J Oncol 12:1029–1034

    PubMed  CAS  Google Scholar 

  • Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M (1999) Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 83:59–65

    PubMed  CAS  Google Scholar 

  • Arzimanoglou II, Lallas T, Osborne M, Barber H, Gilbert F (1996) Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis 17:1799–1804

    PubMed  CAS  Google Scholar 

  • Arzimanoglou II, Gilbert F, Barber H.R. (1998) Microsatellite instability in human solid tumors. Cancer 82:1808–1820

    PubMed  CAS  Google Scholar 

  • Berchuck A, Schildkraut J (1997) Oral contraceptive pills. Prevention of ovarian cancer and other benefits. NC Med J 58:404–407

    CAS  Google Scholar 

  • Boland CR, Thibodeau SN, Hamilton SR et al.(1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257

    PubMed  CAS  Google Scholar 

  • Boyd J (1998) Molecular genetics of hereditary ovarian cancer. Oncology (Huntingt) 12:399–406

    CAS  Google Scholar 

  • Boyd J, Sonoda Y, Federici MG et al. (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.JAMA 283:2260–2265

    PubMed  CAS  Google Scholar 

  • Bulun SE, Economos K, Miller D, Simpson ER (1994) CYP1 (arornatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 79:1831–1834

    PubMed  CAS  Google Scholar 

  • Burke TW, Heller PB, Woodward JE, Davidson SA, Hoskins WJ, Park RC (1990) Treatment failure in endometrial carcinoma.Obstet Gynecol 75:96–101

    PubMed  CAS  Google Scholar 

  • Burks RT, Kessis TD, Cho KR, Hedrick L (1994) Microsatellite instability in endometrial carcinoma. Oncogene9:1163–1166

    PubMed  CAS  Google Scholar 

  • Caduff RF, Johnston CM, Frank TS (1995) Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Am J Pathol 146:182–188

    PubMed Central  PubMed  CAS  Google Scholar 

  • Casey G (1997) The BRCA1 and BRCA2 breast cancer genes.Curr Opin Oncol 9:88–93

    PubMed  CAS  Google Scholar 

  • Cenci M, Nagar C, Giovagnoli MR, Vecchione A (1997) The PAPNET system for quality control of cervical smears: validation and limits. Anticancer Res 17:4731–4734

    PubMed  CAS  Google Scholar 

  • Chen NJ, Okuda H, Sekiba K (1985) Recurrent carcinoma of the vagina following Okabayashi’s radical hysterectomy for cervical carcinoma. Gynecol Oncol 20:10–16

    PubMed  CAS  Google Scholar 

  • Cuzick J, Meijer CJ, Walboomers JM (1998) Screening for cervical cancer. Lancet 351:1439–1440

    PubMed  CAS  Google Scholar 

  • De Vet HC, Knipschild PG, Schouten HJ et al. (1990) Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 43:1395–1398

    PubMed  Google Scholar 

  • De Vet HC, Knipschild PG, Schouten HJ et al. (1992) Sources of interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 45:785–790

    PubMed  Google Scholar 

  • Dunlop MG, Farrington SM, Carothers AD et al. (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105–110

    PubMed  CAS  Google Scholar 

  • Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265–271

    PubMed Central  PubMed  CAS  Google Scholar 

  • Ellenson LH (2000) The molecular biology of endometrial tumorigenesis: does it have a message? Int J Gynecol Pathol 19:310–313

    PubMed  CAS  Google Scholar 

  • Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG (1998) MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17:2413–2417

    PubMed  CAS  Google Scholar 

  • Farghaly SA (1998) BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications. Am J Obstet Gynecol 179:1101–1102

    PubMed  CAS  Google Scholar 

  • Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692–695

    PubMed  CAS  Google Scholar 

  • Ford D, Easton DF, Stratton M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689

    PubMed Central  PubMed  CAS  Google Scholar 

  • Foulkes WD, Narod SA (1995) Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med 18:473–483

    PubMed  CAS  Google Scholar 

  • Gallion HH, Pieretti M, DePriest PD, Nagell JR van (1995) The molecular basis of ovarian cancer. Cancer 76:1992–1997

    PubMed  CAS  Google Scholar 

  • Gissmann L, Boshart M, Durst M, Ikenberg H, Wagner D, zur Hausen H (1984) Presence of human papillomavirus in genital tumors. J luvest Dermatol 83:26s–28s

    CAS  Google Scholar 

  • Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS (2000) Dedining ovarian cancer rates in US women in relation to parity and oral contraceptive use. Epidemiology 11:102–105

    PubMed  CAS  Google Scholar 

  • Gore H (1994) Histopathology of ovarian cancer. Semin Surg Oncol 10:255–260

    PubMed  CAS  Google Scholar 

  • Halford JA, Wright RG, Ditchmen EJ (1999) Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid re screening. Cytopathology10:317–323

    PubMed  CAS  Google Scholar 

  • Han R, Cladel NM, Reed CA, Peng X, Christensen ND (1999) Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes. J Virol 73:7039–7043

    PubMed Central  PubMed  CAS  Google Scholar 

  • Herman JG, Umar A, Polyak K et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95:6870–6875

    PubMed Central  PubMed  CAS  Google Scholar 

  • Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423–428

    PubMed  CAS  Google Scholar 

  • Hoffmann JS, Cazaux C (1998) DNA synthesis, mismatch repair and cancer. Int J Oncol 12:377–382

    PubMed  CAS  Google Scholar 

  • Holowaty P, Miller AB, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252–258

    PubMed  CAS  Google Scholar 

  • Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3–10

    PubMed  CAS  Google Scholar 

  • Hopfl R, Heim K, Christensen N et al. (2000) Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet 356:1985–1986

    PubMed  CAS  Google Scholar 

  • Jansen KU, Rosolowsky M, Schultz LD et al. (1995) Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPVinduced papilloma formation. Vaccine 13:1509–1514

    PubMed  CAS  Google Scholar 

  • Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92:1654–1658

    PubMed Central  PubMed  CAS  Google Scholar 

  • Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989–2997

    PubMed Central  PubMed  CAS  Google Scholar 

  • Jochmus I, Schafer K, Faath S, Muller M, Gissmann L (1999) Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine. Arch Med Res 30:269–274

    PubMed  CAS  Google Scholar 

  • Kirnbauer R (1996) Papillomavirus-like particles for serology and vaccine development. Intervirology 39:54–61

    PubMed  CAS  Google Scholar 

  • Kiviat NB, Koutsky LA, Paavonen JA et al. (1989) Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 159:293–302

    PubMed  CAS  Google Scholar 

  • Klaes R, Woerner SM, Ridder R et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transeripts derived from integrated papillomavirus oncogenes. Cancer Res 59:6132–6136

    PubMed  CAS  Google Scholar 

  • Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of p16INK4a as specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284

    PubMed  CAS  Google Scholar 

  • Knebel DM von (1992a) Papillomaviruses in human disease: Part I. Pathogenesis and epidemiology of human papillomavirus infections. Eur J Med 1:415–423

    Google Scholar 

  • Knebel DM von (1992b) Papillomaviruses in human disease: Part 11.Molecular biology and immunology of papillomavirus infections and careinogenesis. Eur J Med 1:485–491

    Google Scholar 

  • Knebel DM von, Gissmann L (1987) Analysis of the biological role of human papilloma virus (HPV)-encoded transcripts in cervical carcinoma cells by antisense RNA. Hamatol Bluttransfus 31:377–379

    Google Scholar 

  • Knebel DM von, Oltersdorf T, Schwarz E, Gissmann L (1988) Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48:3780–3786

    Google Scholar 

  • Knebel DM von, Bauknecht T, Bartsch D, zur Hausen H (1991) Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA 88:1411–1415

    Google Scholar 

  • Knebel DM von, Rittmuller C, zur Hausen H, Durst M (1992) Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer 51:831–834

    Google Scholar 

  • Knebel Doeberitz M von, Rittmüller C, Aengenyndt F, Jansen-Dürr P, Spitkovsky D (1994) Reversible repression of papillomavirus oncoproteins in cervical carcinoma cells: consequences for the phenotype and p53 and pRB interactions. J Virol 68:2811–2821

    Google Scholar 

  • Kong D, Suzuki A, Zou TT et al. (1997)PTEN1 is frequently mutated in primary endometrial careinomas. Nat Genet 17:143–144

    PubMed  CAS  Google Scholar 

  • Kovalev S, Marchenko ND, Gugliotta BG, Chalas E, Chumas J, Moll UM (1998) Loss of p53 function in uterine papillary serous carcinoma. Hum Pathol 29:613–619

    PubMed  CAS  Google Scholar 

  • Launonen V, Mannermaa A, Stenback F et al. (2000) Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet 122:49–54

    PubMed  CAS  Google Scholar 

  • Lax SF, Kurman RJ (1997) A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 81:228–232

    PubMed  CAS  Google Scholar 

  • Leigh IM, Buchanan JA, Harwood CA, Cerio R, Storey A (1999) Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression. J Acquir Immune Defic Syndr Hum Retrovirol [Suppl 1] 21:S49–S57

    Google Scholar 

  • Lengauer C, Kinzier KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649

    PubMed  CAS  Google Scholar 

  • Levenson AS, Jordan VC (1998) The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor. Cancer Res 58:1872–1875

    PubMed  CAS  Google Scholar 

  • Levine RL, Cargile CB, Blazes MS, Rees B van, Kurman RJ, Ellenson LH (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, aprecursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258

    PubMed  CAS  Google Scholar 

  • Lin YL, Borenstein LA, Ahmed R, Wettstein FO (1993) Cottontail rabbit papillomavirus LI protein-based vaceines: protection is achieved only with a full-length, nondenatured product. J Virol 67:4154–4162

    PubMed Central  PubMed  CAS  Google Scholar 

  • Lowy DR, Schiller JT (1999) Papillomaviruses: prophylactic vaccine prospects. Biochim Biophys Acta 1423:M1–M8

    PubMed  CAS  Google Scholar 

  • Luft F, Gebert J, Schneider A, Melsheimer P, Knebel DM von (1999) Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol 18:374–380

    PubMed  CAS  Google Scholar 

  • Lynch HT, de la Chapelle CA (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801–818

    PubMed Central  PubMed  CAS  Google Scholar 

  • Mann GB, Borgen P.I. (1998) Breast cancer genes and the surgeon. J Surg Oncol 67:267–274

    PubMed  CAS  Google Scholar 

  • Marcus VA, Madlensky L, Gryfe R et al. (1999) Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248–1255

    PubMed  CAS  Google Scholar 

  • Marsden DE, Friedlander M, Hacker NMF (2000) Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol 19:11–19

    PubMed  CAS  Google Scholar 

  • Melbye M, Sprogel P (1991) Actiological parallel between anal cancer and cervical cancer. Lancet 338:657–659

    PubMed  CAS  Google Scholar 

  • Mutter GL, Lin MC, Fitzgerald JT et al. (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–930

    PubMed  CAS  Google Scholar 

  • Myers MP, Pass I, Batty IH et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95:13513–13518

    PubMed Central  PubMed  CAS  Google Scholar 

  • Nieminen P, Kallio M, Anttila A, Hakama M (1999) Organised vs. spontaneous Pap-smear screening for cervical cancer: a case-control study. Int J Cancer 83:55–58

    PubMed  CAS  Google Scholar 

  • Osen W, Jochmus I, Muller M, Gissmann L (2000) Immunization against human papillomavirus infection and associated eoplasia. J Clin Virol 19:75–78

    PubMed  CAS  Google Scholar 

  • Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186–192

    PubMed  CAS  Google Scholar 

  • O’Suilivan JP (1998) Observer variation in gynaecological cytopathology. Cytopathology 9:6–14

    Google Scholar 

  • O’Sullivan JP, Ismail SM, Barnes WS et al. (1994) Interobserver variation in the diagnosis and grading of dyskaryosis in cervical smears: specialist cytopathologists compared with non-specialists. J Clin Pathol 47:515–518

    CAS  Google Scholar 

  • Pagano M, Durst M, Joswig S, Draetta G, Jansen-Durr P (1992) Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene 7:1681–1686

    PubMed  CAS  Google Scholar 

  • Papanicolaou GN, Traut HF (1997) The diagnostic value of vaginal smears in carcinoma of the uterus. Arch Pathol Lab Med 121:211–224

    PubMed  CAS  Google Scholar 

  • Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841

    PubMed  CAS  Google Scholar 

  • Perego P, Giarola M, Righetti SC et al. (1996) Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 56:556–562

    PubMed  CAS  Google Scholar 

  • Petry KU, Bohmer G, Iftner T, Flemming P, Stoll M, Schmidt RE (1999) Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998. Gynecol Oncol 75:427–431

    Google Scholar 

  • Planck M, Wenngren E, Borg A, Olsson H, Nilbert M (2000) Somatic frameshift alterations in mononucleotide repeatcontaining genes in different tumor types from an HNPCC family with germline MSH2 mutation. Genes Chromosomes Cancer 29:33–39

    PubMed  CAS  Google Scholar 

  • Reuter S, Bartelmann M, Vogt M et al. (1998) APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J 17:215–222

    PubMed Central  PubMed  CAS  Google Scholar 

  • Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J (1993) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53:5100–5103

    PubMed  CAS  Google Scholar 

  • Risinger JI, Umar A, Boyer JC et al. (1995) Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. Cancer Res 55:5664-5669

    Google Scholar 

  • Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMACI mutations in endometrial cancers. Cancer Res 57:4736–4738

    PubMed  CAS  Google Scholar 

  • Risinger JI, Hayes K, Maxwell GL et al. (1998) PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 4:3005–3010

    PubMed  CAS  Google Scholar 

  • Saffari B, Jones LA, Naggar A el, Felix JC, George J, Press MF (1995) Amplification and overexpression of HER-21 neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res 55:5693–5698

    PubMed  CAS  Google Scholar 

  • Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998) Expression status of p 16 protein is associated with human papillomavirus oncogenic potential in cervical and genitallesions. Am J Pathol 153:1741–1748

    PubMed Central  PubMed  CAS  Google Scholar 

  • Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505

    PubMed  CAS  Google Scholar 

  • Scully RE (1975) World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer lust Monogr 42:5–7

    CAS  Google Scholar 

  • Segnan N (1994) Cervical cancer screening. Human benefits and human costs in the evaluation of screening programmes. Eur J Cancer 30A:873–875

    PubMed  CAS  Google Scholar 

  • Selvakumar R, Borenstein LA, Lin YL, Ahmed R, Wettstein FO (1995) Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J Virol 69:602–605

    PubMed Central  PubMed  CAS  Google Scholar 

  • Shattuck-Eidens D, McClure M, Simard J et al. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273:535–541

    PubMed  CAS  Google Scholar 

  • Sherman ME (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13:295–308

    PubMed  CAS  Google Scholar 

  • Sherman ME, Schiffman M, Herrero R et al. (1998) Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica. Cancer 84:273–280

    PubMed  CAS  Google Scholar 

  • Simpkins SB, Bocker T, Swisher EM et al. (1999) MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 8:661–666

    PubMed  CAS  Google Scholar 

  • Sirchia SM, Sironi E, Grati FR et al. (2000) Losses of heterozygosity in endometrial adenocarcinomas: positive correlations with histopathological parameters. Cancer Genet Cytogenet 121:156–162

    PubMed  CAS  Google Scholar 

  • Smith LH, Oi RH (1984) Detection of malignant ovarian neoplasms: a review of the literature. I. Detection of the patient at risk; clinical, radiological and cytological detection. Obstet Gynecol Surv 39:313–328

    PubMed  CAS  Google Scholar 

  • Soler ME, Blumenthai PD (2000) New technologies in cervical cancer precursor detection. Curr Opin Oncol 12:460–465

    PubMed  CAS  Google Scholar 

  • Solomon D, Schiffman M, Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer lust 93:293–299

    CAS  Google Scholar 

  • Sutcliffe S, Pharoah PD, Easton DF, Ponder BA (2000) Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer87:110–117

    PubMed  CAS  Google Scholar 

  • Suzich JA, Ghim SJ, Palmer-Hill FJ et al. (1995) Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92:11553–11557

    PubMed Central  PubMed  CAS  Google Scholar 

  • Tashiro H, Blazes MS, Wu R et al. (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57:3935–3940

    PubMed  CAS  Google Scholar 

  • Taylor MR (2001) Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician. Postgrad Med J 77:11–15

    PubMed Central  PubMed  CAS  Google Scholar 

  • Tritz D, Pieretti M, Turner S, Powell D (1997) Loss of heterozygosity in usual and special variant carcinomas of the endometrium. Hum Pathol 28:607–612

    PubMed  CAS  Google Scholar 

  • Viikki M, Pukkala E, Hakama M (1998) Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology. Obstet Gynecol 92:269–273

    PubMed  CAS  Google Scholar 

  • Walboomers JM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    PubMed  CAS  Google Scholar 

  • Yamada H, Sasaki M, Honda T et al. (1995) Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18. Genes Chromosomes Cancer 13:18–24

    PubMed  CAS  Google Scholar 

  • Yang X, Lippman ME (1999) BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat 54:1–10

    PubMed  CAS  Google Scholar 

  • Yokoyama M, Nakao Y, Yang X et al. (1995) Alterations in physical state and expression of human papillomavirus type 18 DNA following crisis and establishment of immortalized ectocervical cells. Virus Res 37:139–151

    PubMed  CAS  Google Scholar 

  • Zerfass K, Levy LM, Cremonesi C et al. (1995) Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7. J Gen Virol 76:1815–1820

    PubMed  CAS  Google Scholar 

  • Zheng L, Li S, Boyer TG, Lee WH (2000) Lessons learned from BRCAI and BRCA2. Oncogene 19:6159–6175

    PubMed  CAS  Google Scholar 

  • Zuna RE (1984) The Pap smear revisited. Controversies and recent developments. Postgrad Med 76:36–46

    PubMed  CAS  Google Scholar 

  • zur Hausen H (1999) Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9:405–411

    PubMed  Google Scholar 

  • zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690–698

    PubMed  Google Scholar 

  • Zweemer RP, Verheijen RH, Menko FH et al. (1999) Differences between hereditary and sporadic ovarian cancer. Eur J Obstet Gynecol Reprod Biol 82:151–153

    PubMed  CAS  Google Scholar 

  • Zwerschke W, Jansen-Durr P (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78:1–29

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Magnus von Knebel Doeberitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Str.10, 13122, Berlin-Buch, Germany

    Detlev Ganten  & Klaus Ruckpaul  & 

  2. Medizinische Universitätsklinik Knappschaftskrankenhaus, In der Schornau 23-25, 44892, Bochum-Langendreer, Germany

    Stephan A. Hahn  & Wolff Schmiegel  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Knebel Doeberitz, M. (2002). Molekulare Pathogenese der Malignome des Genitalbereichs. In: Ganten, D., Ruckpaul, K., Hahn, S.A., Schmiegel, W. (eds) Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56297-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56297-6_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62572-5

  • Online ISBN: 978-3-642-56297-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation